<s id="wsj_0225.1"> 40
2 	 0 	 N/N 	 1 	 Co. Dow
2 	 1 	 N/N 	 1 	 Co. Chemical
2 	 4 	 NP\NP 	 1 	 Co. Midland
2 	 6 	 NP\NP 	 1 	 Co. Mich. <XU>
2 	 16 	 (S[dcl]\NP)/S[dcl] 	 1 	 Co. said
12 	 9 	 N/N 	 1 	 Co. Eli
12 	 10 	 N/N 	 1 	 Co. Lilly
12 	 11 	 N/N 	 1 	 Co. &
12 	 14 	 NP\NP 	 1 	 Co. Indianapolis
12 	 16 	 (S[dcl]\NP)/S[dcl] 	 1 	 Co. said
17 	 18 	 (S[dcl]\NP)/NP 	 1 	 they completed
18 	 16 	 (S[dcl]\NP)/S[dcl] 	 2 	 completed said
20 	 18 	 (S[dcl]\NP)/NP 	 2 	 formation completed
20 	 19 	 NP[nb]/N 	 1 	 formation the
20 	 21 	 (NP\NP)/NP 	 1 	 formation of
23 	 21 	 (NP\NP)/NP 	 2 	 Elanco of
23 	 22 	 N/N 	 1 	 Elanco Dow
27 	 21 	 (NP\NP)/NP 	 2 	 venture of
27 	 25 	 NP[nb]/N 	 1 	 venture a
27 	 26 	 N/N 	 1 	 venture joint
27 	 28 	 (S[ng]\NP)/NP 	 1 	 venture combining <XB>
31 	 28 	 (S[ng]\NP)/NP 	 2 	 businesses combining
31 	 29 	 NP[nb]/N 	 1 	 businesses their
31 	 30 	 N/N 	 1 	 businesses plant-sciences
34 	 32 	 conj/conj 	 1 	 as as
34 	 33 	 conj/conj 	 1 	 as well
35 	 36 	 (NP[nb]/N)\NP 	 2 	 Dow 's
39 	 28 	 (S[ng]\NP)/NP 	 2 	 business combining
39 	 36 	 (NP[nb]/N)\NP 	 1 	 business 's
39 	 37 	 N/N 	 1 	 business industrial
39 	 38 	 N/N 	 1 	 business pest-control
<\s>
<s id="wsj_0225.2"> 24
1 	 0 	 NP[nb]/N 	 1 	 companies The
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 companies said
4 	 3 	 N/N 	 1 	 Elanco Dow
4 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Elanco will
4 	 6 	 (S[b]\NP)/NP 	 1 	 Elanco be <XB>
5 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 will said
6 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
6 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 be with
11 	 6 	 (S[b]\NP)/NP 	 2 	 concern be
11 	 7 	 NP[nb]/N 	 1 	 concern the
11 	 8 	 N/N 	 1 	 concern largest
11 	 9 	 N/N 	 1 	 concern research-based
11 	 10 	 N/N 	 1 	 concern agricultural
11 	 12 	 (NP\NP)/NP 	 1 	 concern in
14 	 12 	 (NP\NP)/NP 	 2 	 America in
14 	 13 	 N/N 	 1 	 America North
19 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 revenue with
19 	 17 	 N/N 	 1 	 revenue projected
19 	 18 	 N/N 	 1 	 revenue first-year
19 	 20 	 (NP\NP)/NP 	 1 	 revenue of
21 	 20 	 (NP\NP)/NP 	 2 	 $ of
23 	 21 	 N/N[num] 	 1 	 billion $
23 	 22 	 N/N 	 1 	 billion 1.5
<\s>
<s id="wsj_0225.3"> 15
0 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Dow will
0 	 2 	 (S[b]\NP)/NP 	 1 	 Dow own <XB>
2 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 own will
2 	 9 	 (((S\NP)\(S\NP))/(S[ng]\NP))/NP 	 2 	 own with
4 	 2 	 (S[b]\NP)/NP 	 2 	 % own
4 	 3 	 N/N 	 1 	 % 60
4 	 5 	 (NP\NP)/NP 	 1 	 % of
7 	 5 	 (NP\NP)/NP 	 2 	 venture of
7 	 6 	 NP[nb]/N 	 1 	 venture the
11 	 9 	 (((S\NP)\(S\NP))/(S[ng]\NP))/NP 	 4 	 Lilly with
11 	 10 	 N/N 	 1 	 Lilly Eli
11 	 12 	 (S[ng]\NP)/NP 	 1 	 Lilly holding <XB>
12 	 9 	 (((S\NP)\(S\NP))/(S[ng]\NP))/NP 	 3 	 holding with
14 	 12 	 (S[ng]\NP)/NP 	 2 	 rest holding
14 	 13 	 NP[nb]/N 	 1 	 rest the
<\s>
<s id="wsj_0225.4"> 7
1 	 0 	 NP[nb]/N 	 1 	 venture The
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 venture will
1 	 4 	 S[pss]\NP 	 1 	 venture based <XB>
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
4 	 3 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 based be
4 	 5 	 ((S\NP)\(S\NP))/NP 	 2 	 based in
6 	 5 	 ((S\NP)\(S\NP))/NP 	 3 	 Indianapolis in
<\s>
